Document Detail


Pharmacological stimulation of type 5 adenylyl cyclase stabilizes heart rate under both microgravity and hypergravity induced by parabolic flight.
MedLine Citation:
PMID:  22850613     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We previously demonstrated that type 5 adenylyl cyclase (AC5) functions in autonomic regulation in the heart. Based on that work, we hypothesized that pharmacological modulation of AC5 activity could regulate the autonomic control of the heart rate under micro- and hypergravity. To test this hypothesis, we selected the approach of activating AC5 activity in mice with a selective AC5 activator (NKH477) or inhibitor (vidarabine) and examining heart rate variability during parabolic flight. The standard deviation of normal R-R intervals, a marker of total autonomic variability, was significantly greater under micro- and hypergravity in the vidarabine group, while there were no significant changes in the NKH477 group, suggesting that autonomic regulation was unstable in the vidarabine group. The ratio of low frequency and high frequency (HF) in heart rate variability analysis, a marker of sympathetic activity, became significantly decreased under micro- and hypergravity in the NKH477 group, while there was no such decrease in the vidarabine group. Normalized HF, a marker of parasympathetic activity, became significantly greater under micro- and hypergravity in the NKH477 group. In contrast, there was no such increase in the vidarabine group. This study is the first to indicate that pharmacological modulation of AC5 activity under micro- and hypergravity could be useful to regulate the autonomic control of the heart rate.
Authors:
Yunzhe Bai; Takashi Tsunematsu; Qibin Jiao; Yoshiki Ohnuki; Yasumasa Mototani; Kouichi Shiozawa; Meihua Jin; Wenqian Cai; Hui-Ling Jin; Takayuki Fujita; Yasuhiro Ichikawa; Kenji Suita; Reiko Kurotani; Utako Yokoyama; Motohiko Sato; Kousaku Iwatsubo; Yoshihiro Ishikawa; Satoshi Okumura
Related Documents :
17885073 - Quantification of left ventricular noncompaction and trabecular delayed hyperenhancemen...
19091793 - Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron o...
3416743 - Verapamil preceded by calcium in supraventricular tachycardia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-07-31
Journal Detail:
Title:  Journal of pharmacological sciences     Volume:  119     ISSN:  1347-8648     ISO Abbreviation:  J. Pharmacol. Sci.     Publication Date:  2012  
Date Detail:
Created Date:  2012-09-14     Completed Date:  2013-01-29     Revised Date:  2013-06-06    
Medline Journal Info:
Nlm Unique ID:  101167001     Medline TA:  J Pharmacol Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  381-9     Citation Subset:  IM    
Affiliation:
Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenylate Cyclase / antagonists & inhibitors,  physiology*
Animals
Forskolin / analogs & derivatives,  pharmacology
Heart Rate / drug effects,  physiology*
Hypergravity*
Male
Mice
Mice, Inbred C57BL
Vidarabine / pharmacology
Weightlessness*
Chemical
Reg. No./Substance:
1F7A44V6OU/colforsin; 5536-17-4/Vidarabine; 66428-89-5/Forskolin; EC 4.6.1.1/Adenylate Cyclase; EC 4.6.1.1/adenylyl cyclase type V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation...
Next Document:  Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human ami...